Poulami Talukder

Principal Scientist Tiba Biotech

Poulami Talukder, PhD is a Principal Scientist and the Formulation Lead at Tiba Biotech in Cambridge, MA, specializing in nucleic acid delivery and nanoparticle design. She focuses on developing advanced delivery tools for RNA-based vaccines and therapeutics, integrating targeted drug delivery with medicinal chemistry. Prior to her current role, Dr. Talukder held research positions at leading institutions including the Dana-Farber Cancer Institute, University of California, San Francisco, and Arizona State University, where she contributed to innovative projects in organic chemistry and biomedical research. Her interdisciplinary expertise bridges fundamental chemistry with translational delivery technologies, advancing next-generation therapeutic and vaccine platforms.

Seminars

Monday 20th July 2026
Low-Inflammatory RNABL Delivery Enables Organ-Specific Therapeutic RNA Applications
2:30 pm
  • Introducing non-inflammatory, biodegradable RNABL dendritic molecules for nucleic acid complexation and in vivo delivery
  • Showcasing Organ tunability and safety profile of RNABL formulations
  • Demonstrating successful therapeutic applications in animal models
Poulami Talukder - 6th mRNA-Based Therapeutics Summit Speaker